Egetis Therapeutics
Develops and commercializes treatments for serious and rare diseases.
EGTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0003815604
- LEI:
- 549300RZCKGWRUBPMY22
- Country:
- Sweden
- Address:
- Klara Norra Kyrkogata 26, 111 22 Stockholm
- Website:
- https://www.egetis.com/
- Sector:
- Manufacturing
Description
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on developing and commercializing treatments for serious and rare diseases with significant unmet medical needs. The company's strategy centers on advancing drug candidates through late-stage clinical development to market approval. Its primary asset, Emcitate (tiratricol), is a first-in-class drug candidate in late-stage development for the treatment of Monocarboxylate Transporter 8 (MCT8) deficiency, a rare congenital disorder of thyroid hormone transport.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-19 08:00 |
Egetis Therapeutics tillförs cirka 180 MSEK genom övertecknad företrädesemission
|
Swedish | 86.1 KB | ||
| 2022-05-18 11:10 | English | 33.9 KB | |||
| 2022-05-17 21:53 | English | 34.1 KB | |||
| 2022-04-28 14:20 |
Egetis Therapeutics publishes prospectus relating to the Rights Issue
|
English | 59.4 KB | ||
| 2022-04-28 14:20 |
Egetis Therapeutics offentliggör prospekt avseende företrädesemissionen
|
Swedish | 63.3 KB | ||
| 2022-04-26 08:00 | Swedish | 629.7 KB | |||
| 2022-04-26 08:00 | English | 703.3 KB | |||
| 2022-04-20 00:00 | Swedish | 60.1 MB | |||
| 2022-04-13 13:00 |
Kommuniké från extra bolagsstämma i Egetis Therapeutics AB samt offentliggörand…
|
Swedish | 73.7 KB | ||
| 2022-04-13 13:00 |
Bulletin from extraordinary shareholders’ meeting in Egetis Therapeutics AB and…
|
English | 71.0 KB | ||
| 2022-03-21 08:05 |
NOTICE OF EXTRAORDINARY GENERAL MEETING IN EGETIS THERAPEUTICS
|
English | 73.3 KB | ||
| 2022-03-21 08:05 |
KALLELSE TILL EXTRA BOLAGSSTÄMMA I EGETIS THERAPEUTICS
|
Swedish | 77.7 KB | ||
| 2022-03-21 08:00 |
Egetis Therapeutics beslutar om en fullt garanterad företrädesemission om cirka…
|
Swedish | 241.8 KB | ||
| 2022-03-21 08:00 |
Egetis Therapeutics resolves on a fully guaranteed preferential rights issue of…
|
English | 194.1 KB | ||
| 2022-02-17 08:00 | Swedish | 351.3 KB |
Automate Your Workflow. Get a real-time feed of all Egetis Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Egetis Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Egetis Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-09 | Yilmaz Mahshid | Other | Sell | 39,753 | 268,332.75 SEK |
| 2025-01-08 | Yilmaz Mahshid | Other | Sell | 98,567 | 653,499.21 SEK |
| 2025-01-07 | Yilmaz Mahshid | Other | Sell | 74,769 | 507,681.51 SEK |
| 2024-10-07 | Nicklas Westerholm | Other | Buy | 10,142 | 43,103.50 SEK |
| 2024-10-07 | Yilmaz Mahshid | Other | Buy | 10,000 | 42,250.00 SEK |
| 2023-07-07 | Henrik Krook | Other | Buy | 33,594 | 133,704.12 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 3,616 | 14,391.68 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 2,000 | 7,920.00 SEK |
| 2023-07-05 | Christian Sonesson | Other | Buy | 1,384 | 5,452.96 SEK |
| 2023-07-04 | Nicklas Westerholm | Other | Buy | 15,350 | 60,632.50 SEK |
Peer Companies
